$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz

$jazz Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000123252421000016 Filed on February 23, 2021

Income Statement

Concept	2020 Q4	2020 Q3	2020 Q2
Revenue	$665.5M	$600.9M	$562.4M
YoY Change	14.4%	11.75%	5.3%
Cost Of Revenue	$50.20M	$42.10M	$28.00M
YoY Change	42.21%	34.08%	1.08%
Gross Profit	$611.1M	$554.9M	$530.2M
YoY Change	12.93%	10.77%	6.95%
Gross Profit Margin	91.83%	92.34%	94.27%
Selling, General & Admin	$247.2M	$207.3M	$191.4M
YoY Change	15.35%	15.98%	8.74%
% of Gross Profit	40.45%	37.35%	36.1%
Research & Development	$127.7M	$78.65M	$78.92M
YoY Change	31.11%	-1.51%	26.51%
% of Gross Profit	20.9%	14.17%	14.89%
Depreciation & Amortization	$71.70M	$71.50M	$67.80M
YoY Change	-59.7%	7.04%	4.31%
% of Gross Profit	11.73%	12.89%	12.79%
Operating Expenses	$441.9M	$285.9M	$270.3M
YoY Change	-8.92%	10.57%	13.39%
Operating Profit	$169.2M	$196.2M	$198.1M
YoY Change	202.34%	47.41%	-3.01%
Interest Expense	-$28.60M	-$27.43M	-$26.21M
YoY Change	39.51%	53.56%	43.74%
% of Operating Profit	-16.9%	-13.98%	-13.23%
Other Income/Expense, Net
YoY Change
Pretax Income	$144.8M	$168.1M	$171.5M
YoY Change	254.9%	47.22%	-6.88%
Income Tax	$10.80M	$19.30M	$54.80M
% Of Pretax Income	7.46%	11.48%	31.96%
Net Earnings	$133.4M	$148.2M	$114.8M
YoY Change	80.31%	44.94%	-56.17%
Net Earnings / Revenue	20.05%	24.67%	20.41%
Basic Earnings Per Share	$2.39	$2.67	$2.07
Diluted Earnings Per Share	$2.33	$2.64	$2.06
COMMON SHARES
Basic Shares Outstanding	55.71M shares	55.55M shares	55.41M shares
Diluted Shares Outstanding		56.24M shares	55.86M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.133B	$1.917B	$1.696B
YoY Change	97.98%	79.12%	92.15%
Cash & Equivalents	$1.058B	$741.9M	$786.1M
Short-Term Investments	$1.616B	$1.511B	$1.226B
Other Short-Term Assets	$152.5M	$127.3M	$112.7M
YoY Change	93.28%	56.33%	49.54%
Inventory	$95.40M	$91.40M	$92.53M
Prepaid Expenses	$62.42M	$58.31M	$49.11M
Receivables	$396.5M	$361.7M	$351.9M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.840B	$2.556B	$2.302B
YoY Change	74.18%	68.07%	68.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$127.9M	$128.2M	$128.3M
YoY Change	-2.72%	-0.98%	0.85%
Goodwill	$958.3M	$937.1M	$918.0M
YoY Change	4.16%	3.35%	-0.75%
Intangibles	$2.195B	$2.241B	$2.286B
YoY Change	-10.07%	-13.57%	-14.95%
Long-Term Investments
YoY Change
Other Assets	$25.72M	$38.65M	$48.83M
YoY Change	-46.32%	-12.71%	19.57%
Total Long-Term Assets	$3.696B	$3.736B	$3.764B
YoY Change	-5.43%	-6.76%	-8.61%
TOTAL ASSETS
Total Short-Term Assets	$2.840B	$2.556B	$2.302B
Total Long-Term Assets	$3.696B	$3.736B	$3.764B
Total Assets	$6.536B	$6.292B	$6.067B
YoY Change	18.0%	13.82%	10.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$26.95M	$67.06M	$50.04M
YoY Change	-41.08%	-4.34%	-39.14%
Accrued Expenses	$352.7M	$302.1M	$266.9M
YoY Change	30.79%	26.53%	22.02%
Deferred Revenue	$2.546M	$3.090M	$3.633M
YoY Change	-46.06%	-34.53%	-23.03%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$246.3M	$244.0M	$33.39M
YoY Change	637.78%	630.82%	0.0%
Total Short-Term Liabilities	$653.7M	$642.1M	$410.0M
YoY Change	79.36%	64.46%	10.95%
LONG-TERM LIABILITIES
Long-Term Debt	$1.849B	$1.844B	$2.070B
YoY Change	17.45%	17.37%	32.01%
Other Long-Term Liabilities	$101.1M	$142.5M	$134.8M
YoY Change	-7.52%	38.89%	11.7%
Total Long-Term Liabilities	$1.950B	$1.986B	$2.205B
YoY Change	15.83%	18.69%	30.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$653.7M	$642.1M	$410.0M
Total Long-Term Liabilities	$1.950B	$1.986B	$2.205B
Total Liabilities	$2.603B	$2.628B	$2.614B
YoY Change	27.14%	27.35%	27.04%
SHAREHOLDERS EQUITY
Retained Earnings	$1.160B	$1.026B	$878.2M
YoY Change	8.62%	-7.04%	-14.06%
Common Stock	$2.634B	$2.538B	$2.499B
YoY Change	16.22%	14.88%	15.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.660B	$3.377B	$3.142B
YoY Change
Total Liabilities & Shareholders Equity	$6.536B	$6.292B	$6.067B
YoY Change	18.0%	13.82%	10.53%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2020 Q2
OPERATING ACTIVITIES
Net Income	$133.4M	$148.2M	$114.8M
YoY Change	80.31%	44.94%	-56.17%
Depreciation, Depletion And Amortization	$71.70M	$71.50M	$67.80M
YoY Change	-59.7%	7.04%	4.31%
Cash From Operating Activities	$186.2M	$257.9M	$182.5M
YoY Change	112.07%	-23.59%	22.65%
INVESTING ACTIVITIES
Capital Expenditures	-$40.20M	-$13.30M	-$105.7M
YoY Change	466.2%	-80.89%	153.48%
Acquisitions
YoY Change
Other Investing Activities	$113.4M	-$266.3M	-$635.5M
YoY Change	-174.61%	195.89%	-1729.49%
Cash From Investing Activities	$73.20M	-$279.7M	-$741.1M
YoY Change	-146.01%	75.25%	27348.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	55.90M	-22.70M	642.6M
YoY Change	-163.74%	16.41%	-1243.42%
NET CHANGE
Cash From Operating Activities	186.2M	257.9M	182.5M
Cash From Investing Activities	73.20M	-279.7M	-741.1M
Cash From Financing Activities	55.90M	-22.70M	642.6M
Net Change In Cash	315.3M	-44.50M	84.00M
YoY Change	-298.3%	-128.09%	-6.56%
FREE CASH FLOW
Cash From Operating Activities	$186.2M	$257.9M	$182.5M
Capital Expenditures	-$40.20M	-$13.30M	-$105.7M
Free Cash Flow	$226.4M	$271.2M	$288.2M
YoY Change	138.57%	-33.38%	51.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	City Area Code CityAreaCode	1
CY2020	dei	Local Phone Number LocalPhoneNumber	634-7800
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Dublin 4
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Entity Registrant Name EntityRegistrantName	Jazz Pharmaceuticals plc
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001232524
CY2019Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:AccruedLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:AccruedLiabilitiesCurrent
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-33500
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L2
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1032470
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	Fifth Floor, Waterloo Exchange
CY2020	dei	Entity Address Address Line2 EntityAddressAddressLine2	Waterloo Road
CY2020	dei	Entity Address Country EntityAddressCountry	IE
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	D04 E5W7
CY2020	dei	Country Region CountryRegion	353
CY2020	dei	Security12b Title Security12bTitle	Ordinary shares, nominal value $0.0001 per share
CY2020	dei	Trading Symbol TradingSymbol	JAZZ
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	5958338704	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56325436	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1057769000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	637344000	USD
CY2020Q4	us-gaap	Investments Investments	1075000000	USD
CY2019Q4	us-gaap	Investments Investments	440000000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5487000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1296000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	396490000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	355987000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	95396000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	78608000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	62422000	USD
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	39434000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	152491000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	78895000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	2839568000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	1630268000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	127935000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	131506000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	129169000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	139385000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2195051000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2440977000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	958303000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	920018000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	254916000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	221403000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	5238000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	7426000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25721000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	47914000	USD
CY2020Q4	us-gaap	Assets Assets	6535901000	USD
CY2019Q4	us-gaap	Assets Assets	5538897000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	26945000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	45732000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	352732000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	269686000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	246322000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	33387000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	25200000	USD
CY2019Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	10965000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2546000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4720000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	653745000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	364490000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2315000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	4861000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1848516000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1573870000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	140035000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	151226000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	130397000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	224095000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	101148000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	109374000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56171000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56171000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56140000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56140000	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2020Q4	jazz	Nonvoting Euro Deferred Shares Par Or Stated Value Per Share NonvotingEuroDeferredSharesParOrStatedValuePerShare	0.01
CY2019Q4	jazz	Nonvoting Euro Deferred Shares Par Or Stated Value Per Share NonvotingEuroDeferredSharesParOrStatedValuePerShare	0.01
CY2020Q4	jazz	Nonvoting Euro Deferred Shares Shares Issued NonvotingEuroDeferredSharesSharesIssued	4000000	shares
CY2019Q4	jazz	Nonvoting Euro Deferred Shares Shares Issued NonvotingEuroDeferredSharesSharesIssued	4000000	shares
CY2020Q4	jazz	Nonvoting Euro Deferred Shares Shares Outstanding NonvotingEuroDeferredSharesSharesOutstanding	4000000	shares
CY2019Q4	jazz	Nonvoting Euro Deferred Shares Shares Outstanding NonvotingEuroDeferredSharesSharesOutstanding	4000000	shares
CY2019Q4	jazz	Nonvoting Euro Preferred Shares Shares Authorized NonvotingEuroPreferredSharesSharesAuthorized	4000000	shares
CY2020Q4	jazz	Nonvoting Euro Preferred Shares Shares Authorized NonvotingEuroPreferredSharesSharesAuthorized	4000000	shares
CY2020Q4	jazz	Nonvoting Euro Deferred Shares NonvotingEuroDeferredShares	55000	USD
CY2019Q4	jazz	Nonvoting Euro Deferred Shares NonvotingEuroDeferredShares	55000	USD
CY2020Q4	jazz	Capital Redemption Reserve CapitalRedemptionReserve	472000	USD
CY2019Q4	jazz	Capital Redemption Reserve CapitalRedemptionReserve	472000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2633670000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2266026000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-134352000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-223393000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1159894000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1067815000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	3659745000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	3110981000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6535901000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5538897000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2363567000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2161761000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1890922000	USD
CY2020	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	148917000	USD
CY2019	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	127930000	USD
CY2018	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	121544000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	854233000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	736942000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	683530000	USD
CY2020	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	335375000	USD
CY2019	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	299726000	USD
CY2018	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	226616000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	259580000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	354814000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	201498000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	136139000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	42896000	USD
CY2020	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	251250000	USD
CY2019	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	109975000	USD
CY2018	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	1985494000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	1629387000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	1276084000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	378073000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	532374000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	614838000	USD
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-99707000	USD
CY2019	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-72261000	USD
CY2018	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-78500000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3271000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5811000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6875000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	275095000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	454302000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	529463000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33517000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-73154000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	80162000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2962000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4089000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2203000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	238616000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	523367000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	447098000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.28
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.22
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.45
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.22
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.09
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.30
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55712000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56749000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59976000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56517000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57550000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61221000	shares
CY2020	us-gaap	Net Income Loss NetIncomeLoss	238616000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	523367000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	447098000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	90183000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-20720000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-58988000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-163000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-697000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	289000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-1142000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-4882000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	2022000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	89041000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-25602000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-56966000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	327657000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	497765000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	390132000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	2713097000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	82918000	USD
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	10419000	USD
CY2018	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	17925000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	102732000	USD
CY2018	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	523672000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-56966000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	447098000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	2757422000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	46477000	USD
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	11354000	USD
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	16739000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	111304000	USD
CY2019	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	301450000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-25602000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	523367000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	3110981000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	3110981000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	176260000	USD
CY2020	jazz	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature Repurchase AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureRepurchase	12513000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	86984000	USD
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	12697000	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	16877000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	121093000	USD
CY2020	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	146537000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	89041000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	238616000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	3659745000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	238616000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	523367000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	447098000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	259580000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	354814000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	201498000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	120998000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	110563000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	102441000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	136139000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	42896000	USD
CY2020	us-gaap	Depreciation Depreciation	18673000	USD
CY2019	us-gaap	Depreciation Depreciation	15342000	USD
CY2018	us-gaap	Depreciation Depreciation	15233000	USD
CY2020	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	251250000	USD
CY2019	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	109975000	USD
CY2018	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
CY2020	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	5438000	USD
CY2019	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	USD
CY2018	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-136937000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-236610000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-88815000	USD
CY2020	jazz	Provision For Losses On Accounts Receivable And Inventory ProvisionForLossesOnAccountsReceivableAndInventory	15000000	USD
CY2019	jazz	Provision For Losses On Accounts Receivable And Inventory ProvisionForLossesOnAccountsReceivableAndInventory	6668000	USD
CY2018	jazz	Provision For Losses On Accounts Receivable And Inventory ProvisionForLossesOnAccountsReceivableAndInventory	4728000	USD
CY2020	jazz	Gain Losson Extinguishmentand Modificationof Debt GainLossonExtinguishmentandModificationofDebt	-5089000	USD
CY2019	jazz	Gain Losson Extinguishmentand Modificationof Debt GainLossonExtinguishmentandModificationofDebt	0	USD
CY2018	jazz	Gain Losson Extinguishmentand Modificationof Debt GainLossonExtinguishmentandModificationofDebt	-1425000	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	56659000	USD
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	46396000	USD
CY2018	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	43960000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-14580000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-59000	USD
CY2018	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-7357000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	38647000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	92326000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	40132000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	30537000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	32790000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18512000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	98042000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	25650000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6697000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-21913000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	18919000	USD
CY2018	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2523000	USD
CY2020	jazz	Increase Decrease In Operating Lease Assets IncreaseDecreaseInOperatingLeaseAssets	-12366000	USD
CY2019	jazz	Increase Decrease In Operating Lease Assets IncreaseDecreaseInOperatingLeaseAssets	-14148000	USD
CY2020	jazz	Increase Decrease In Operating Lease Liabilities Noncurrent IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent	-12383000	USD
CY2018	jazz	Increase Decrease In Operating Lease Assets IncreaseDecreaseInOperatingLeaseAssets	0	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-18935000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4770000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	17040000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	79477000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5565000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	71208000	USD
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	13038000	USD
CY2019	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	10056000	USD
CY2018	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-19735000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-4720000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-5414000	USD
CY2018	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-7497000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-8967000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	3561000	USD
CY2018	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	14537000	USD
CY2019	jazz	Increase Decrease In Operating Lease Liabilities Noncurrent IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent	-6044000	USD
CY2018	jazz	Increase Decrease In Operating Lease Liabilities Noncurrent IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	899648000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	776401000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	798904000	USD
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2397675000	USD
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	917100000	USD
CY2018	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1165915000	USD
CY2020	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	1755000000	USD
CY2019	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	985000000	USD
CY2018	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	855000000	USD
CY2020	jazz	Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination	251250000	USD
CY2019	jazz	Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination	61700000	USD
CY2018	jazz	Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination	0	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15004000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	40135000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20370000	USD
CY2020	jazz	Payment To Acquire Assets Net Of Cash Acquired PaymentToAcquireAssetsNetOfCashAcquired	0	USD
CY2019	jazz	Payment To Acquire Assets Net Of Cash Acquired PaymentToAcquireAssetsNetOfCashAcquired	55074000	USD
CY2018	jazz	Payment To Acquire Assets Net Of Cash Acquired PaymentToAcquireAssetsNetOfCashAcquired	0	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	113000000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	80500000	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	111100000	USD
CY2020	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	14259000	USD
CY2019	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	14209000	USD
CY2018	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	47898000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1007670000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-155300000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-394487000	USD
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	981381000	USD
CY2019	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2018	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	500000000	USD
CY2019	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2018	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	99681000	USD
CY2019	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	57831000	USD
CY2018	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	93337000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	146537000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	301450000	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	523672000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	16877000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	16739000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	17925000	USD
CY2020	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	33387000	USD
CY2019	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	33387000	USD
CY2018	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	25717000	USD
CY2020	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	0	USD
CY2019	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	0	USD
CY2018	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	6406000	USD
CY2020	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	356188000	USD
CY2019	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2018	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2020	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	500000000	USD
CY2019	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2018	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2020	jazz	Payments For Proceeds From Tenant Allowance Financing Activities PaymentsForProceedsFromTenantAllowanceFinancingActivities	0	USD
CY2019	jazz	Payments For Proceeds From Tenant Allowance Financing Activities PaymentsForProceedsFromTenantAllowanceFinancingActivities	0	USD
CY2018	jazz	Payments For Proceeds From Tenant Allowance Financing Activities PaymentsForProceedsFromTenantAllowanceFinancingActivities	-1253000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	528073000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-293745000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-479130000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	374000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	366000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1700000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	420425000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	327722000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-76413000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	637344000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	309622000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	386035000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1057769000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	637344000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	309622000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	42470000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	43002000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	42706000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	226823000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	183610000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	164217000	USD
CY2020	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	USD
CY2019	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	USD
CY2018	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	27747000	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</span></div>
CY2020	us-gaap	Advertising Expense AdvertisingExpense	99600000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	65400000	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	37400000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2132769000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2132769000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1057769000	USD
CY2020Q4	us-gaap	Investments Investments	1075000000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1077344000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1077344000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	637344000	USD
CY2019Q4	us-gaap	Investments Investments	440000000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	11100000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	20500000	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	16900000	USD
CY2020Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	4500000	USD
CY2019Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	4500000	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement	11907000	USD
CY2020Q4	us-gaap	Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement	3625000	USD
CY2019Q4	us-gaap	Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement	2508000	USD
CY2019Q4	us-gaap	Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement	1697000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16003000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	13595000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	45758000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	36658000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	33635000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	28355000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	95396000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	78608000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	195523000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	186763000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	67588000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	55257000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	127935000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	131506000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18700000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15300000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15200000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	920018000	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	38285000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	958303000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3395214000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1200163000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2195051000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3292501000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	990850000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2301651000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3395214000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1200163000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2195051000	USD
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3431827000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	990850000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2440977000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	223608000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	174468000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	174468000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	174468000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	174468000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1273571000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2195051000	USD
CY2020Q4	jazz	Accrued Rebates And Other Sales Deductions AccruedRebatesAndOtherSalesDeductions	127534000	USD
CY2019Q4	jazz	Accrued Rebates And Other Sales Deductions AccruedRebatesAndOtherSalesDeductions	96860000	USD
CY2020Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	102601000	USD
CY2019Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	80531000	USD
CY2020Q4	jazz	Sales Return Reserve SalesReturnReserve	18368000	USD
CY2019Q4	jazz	Sales Return Reserve SalesReturnReserve	3462000	USD
CY2020Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	15230000	USD
CY2019Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	6931000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14457000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12728000	USD
CY2020Q4	jazz	Accrued Inventory Related Liabilities AccruedInventoryRelatedLiabilities	9809000	USD
CY2019Q4	jazz	Accrued Inventory Related Liabilities AccruedInventoryRelatedLiabilities	7816000	USD
CY2020Q4	jazz	Accrued Clinical Trial Liability AccruedClinicalTrialLiability	9108000	USD
CY2019Q4	jazz	Accrued Clinical Trial Liability AccruedClinicalTrialLiability	3141000	USD
CY2020Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	6742000	USD
CY2019Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	10946000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	6660000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7665000	USD
CY2020Q4	jazz	Accrued Interest AccruedInterest	5722000	USD
CY2019Q4	jazz	Accrued Interest AccruedInterest	7540000	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3625000	USD
CY2019Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1037000	USD
CY2020Q4	jazz	Accrued Construction In Progress AccruedConstructionInProgress	1119000	USD
CY2019Q4	jazz	Accrued Construction In Progress AccruedConstructionInProgress	3015000	USD
CY2020Q4	jazz	Accrued Collaboration Costs Current AccruedCollaborationCostsCurrent	444000	USD
CY2019Q4	jazz	Accrued Collaboration Costs Current AccruedCollaborationCostsCurrent	2494000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	31313000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	25520000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	352732000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	269686000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	2094838000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	1607257000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	246322000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	33387000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1848516000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1573870000	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	76100000	USD
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	59100000	USD
CY2018	us-gaap	Interest Expense Debt InterestExpenseDebt	56700000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	252199000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	33387000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	517494000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	575000000	USD
CY2020Q4	jazz	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	1000000000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2378080000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	21755000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	23087000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4079000	USD
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2465000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	3000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	5000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	224000	USD
CY2019	us-gaap	Sublease Income SubleaseIncome	634000	USD
CY2020	us-gaap	Lease Cost LeaseCost	25613000	USD
CY2019	us-gaap	Lease Cost LeaseCost	24923000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	129169000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	139385000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14457000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12728000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	140035000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	151226000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	154492000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	163954000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y8M12D
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	196341000	USD
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y8M12D
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.053
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.053
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	21678000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	17066000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1763000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	153448000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	22393000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	22353000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	22419000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	24277000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	18404000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	86495000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	41849000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	154492000	USD
CY2020Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Due In Next Rolling Twelve Months UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths	112000000.0	USD
CY2020Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	24564000	shares
CY2019Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	22064000	shares
CY2019	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	0	USD
CY2020	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	0	USD
CY2020	jazz	Debt Instrument Covenant Maximum Allowable Dividend And Restricted Payments DebtInstrumentCovenantMaximumAllowableDividendAndRestrictedPayments	30000000	USD
CY2020	jazz	Debt Instrument Covenant Maximum Allowable Restricted Payments DebtInstrumentCovenantMaximumAllowableRestrictedPayments	100000000	USD
CY2020	jazz	Debt Instrument Covenant Maximum Secured Leverage Ratio For Restricted Payments To Be Allowed DebtInstrumentCovenantMaximumSecuredLeverageRatioForRestrictedPaymentsToBeAllowed	3
CY2020	jazz	Debt Instrument Covenant Minimum Total Leverage Ratio Allowable Restricted Payments DebtInstrumentCovenantMinimumTotalLeverageRatioAllowableRestrictedPayments	2
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1890922000	USD
CY2020	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	85640000	USD
CY2020	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-3401000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	89041000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	238616000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	523367000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	447098000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55712000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56749000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59976000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	805000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	801000	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1245000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56517000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57550000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61221000	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.28
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.22
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.45
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.22
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.09
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.30
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
CY2020Q4	jazz	Property Plant And Equipment Net And Operating Lease Right Of Use Assets PropertyPlantAndEquipmentNetAndOperatingLeaseRightOfUseAssets	257104000	USD
CY2019Q4	jazz	Property Plant And Equipment Net And Operating Lease Right Of Use Assets PropertyPlantAndEquipmentNetAndOperatingLeaseRightOfUseAssets	270891000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2363567000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2161761000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1890922000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2363567000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2161761000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	9581000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4720000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4861000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	120998000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	110563000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	102441000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	12838000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	15712000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	17230000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	108160000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	94851000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	85211000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	3900000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	5100000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	7700000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5834000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	131.57
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	823000	shares
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	372910000	USD
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	118.59
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	780000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	111.47
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	281000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	137.73
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	317000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	159.41
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5279000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	130.51
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M18D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	180493000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	5064000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	130.57
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y2M12D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	180763000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3441000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	130.32
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y2M12D
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	125469000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	26400000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	26200000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	43400000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-102328000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-6451000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	170666000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	317728000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	294621000	USD
CY2020	jazz	Income Loss From Continuing Operations Before Income Taxes Foreign Other IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeignOther	4513000	USD
CY2019	jazz	Income Loss From Continuing Operations Before Income Taxes Foreign Other IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeignOther	143025000	USD
CY2018	jazz	Income Loss From Continuing Operations Before Income Taxes Foreign Other IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeignOther	64176000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	275095000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	454302000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	529463000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	19437000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	51696000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	33431000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	110896000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	109495000	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	95143000	USD
CY2020	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	40121000	USD
CY2019	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	2265000	USD
CY2018	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	40403000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	170454000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	163456000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	168977000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-32458000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-163626000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-12408000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-29117000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-41297000	USD
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-41337000	USD
CY2020	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-73599000	USD
CY2019	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-37244000	USD
CY2018	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-34545000	USD
CY2020	jazz	Deferred Income Tax Expense Benefit Before Effect Of Change In Tax Rates DeferredIncomeTaxExpenseBenefitBeforeEffectOfChangeInTaxRates	-135174000	USD
CY2019	jazz	Deferred Income Tax Expense Benefit Before Effect Of Change In Tax Rates DeferredIncomeTaxExpenseBenefitBeforeEffectOfChangeInTaxRates	-242167000	USD
CY2018	jazz	Deferred Income Tax Expense Benefit Before Effect Of Change In Tax Rates DeferredIncomeTaxExpenseBenefitBeforeEffectOfChangeInTaxRates	-88290000	USD
CY2020	jazz	Deferred Foreign Income Tax Expense Benefit Increase Decrease In Tax Rate DeferredForeignIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate	-371000	USD
CY2019	jazz	Deferred Foreign Income Tax Expense Benefit Increase Decrease In Tax Rate DeferredForeignIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate	203000	USD
CY2018	jazz	Deferred Foreign Income Tax Expense Benefit Increase Decrease In Tax Rate DeferredForeignIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate	-538000	USD
CY2020	jazz	Deferred Other Income Tax Expense Benefit Increase Decrease In Tax Rate DeferredOtherIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate	-1392000	USD
CY2019	jazz	Deferred Other Income Tax Expense Benefit Increase Decrease In Tax Rate DeferredOtherIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate	5354000	USD
CY2018	jazz	Deferred Other Income Tax Expense Benefit Increase Decrease In Tax Rate DeferredOtherIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate	13000	USD
CY2020	jazz	Deferred Income Tax Expense Benefit Increase Decrease In Tax Rate DeferredIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate	-1763000	USD
CY2019	jazz	Deferred Income Tax Expense Benefit Increase Decrease In Tax Rate DeferredIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate	5557000	USD
CY2018	jazz	Deferred Income Tax Expense Benefit Increase Decrease In Tax Rate DeferredIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate	-525000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-136937000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-236610000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-88815000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33517000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-73154000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	80162000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33500000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	80200000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.119
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.059
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.001
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-73200000	USD
CY2019	jazz	Discrete Income Tax Expense Benefit Resulting From Intra Entity Intellectual Property Asset Transfer DiscreteIncomeTaxExpenseBenefitResultingFromIntraEntityIntellectualPropertyAssetTransfer	-112300000	USD
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.122
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.161
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.151
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.125
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.125
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.125
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.118
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.088
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.030
CY2020	jazz	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Consolidated Subsidiary Percent EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfConsolidatedSubsidiaryPercent	0.094
CY2019	jazz	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Consolidated Subsidiary Percent EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfConsolidatedSubsidiaryPercent	0.052
CY2018	jazz	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Consolidated Subsidiary Percent EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfConsolidatedSubsidiaryPercent	0.005
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.060
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.087
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.011
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.031
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.018
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.012
CY2020	jazz	Effective Income Tax Rate Reconciliation Nondeductible Expense Financing Costs Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseFinancingCostsPercent	0.026
CY2019	jazz	Effective Income Tax Rate Reconciliation Nondeductible Expense Financing Costs Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseFinancingCostsPercent	-0.017
CY2018	jazz	Effective Income Tax Rate Reconciliation Nondeductible Expense Financing Costs Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseFinancingCostsPercent	-0.043
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.022
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.033
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.032
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.019
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.001
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.004
CY2020	jazz	Effective Income Tax Rate Reconciliation Change In Estimate Percent EffectiveIncomeTaxRateReconciliationChangeInEstimatePercent	-0.013
CY2019	jazz	Effective Income Tax Rate Reconciliation Change In Estimate Percent EffectiveIncomeTaxRateReconciliationChangeInEstimatePercent	0.003
CY2018	jazz	Effective Income Tax Rate Reconciliation Change In Estimate Percent EffectiveIncomeTaxRateReconciliationChangeInEstimatePercent	-0.011
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.007
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.015
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.001
CY2020	jazz	Effective Income Tax Rate Reconciliation Deduction On Subsidiary Equity Percent EffectiveIncomeTaxRateReconciliationDeductionOnSubsidiaryEquityPercent	-0.001
CY2019	jazz	Effective Income Tax Rate Reconciliation Deduction On Subsidiary Equity Percent EffectiveIncomeTaxRateReconciliationDeductionOnSubsidiaryEquityPercent	0
CY2018	jazz	Effective Income Tax Rate Reconciliation Deduction On Subsidiary Equity Percent EffectiveIncomeTaxRateReconciliationDeductionOnSubsidiaryEquityPercent	0.048
CY2020	jazz	Effective Income Tax Rate Reconciliation Intra Entity Transfer Of Intellectual Property Assets Percent EffectiveIncomeTaxRateReconciliationIntraEntityTransferOfIntellectualPropertyAssetsPercent	0
CY2019	jazz	Effective Income Tax Rate Reconciliation Intra Entity Transfer Of Intellectual Property Assets Percent EffectiveIncomeTaxRateReconciliationIntraEntityTransferOfIntellectualPropertyAssetsPercent	0.247
CY2018	jazz	Effective Income Tax Rate Reconciliation Intra Entity Transfer Of Intellectual Property Assets Percent EffectiveIncomeTaxRateReconciliationIntraEntityTransferOfIntellectualPropertyAssetsPercent	0
CY2020	jazz	Effective Income Tax Rate Reconciliation Patent Box Incentive Benefit Percent EffectiveIncomeTaxRateReconciliationPatentBoxIncentiveBenefitPercent	0
CY2019	jazz	Effective Income Tax Rate Reconciliation Patent Box Incentive Benefit Percent EffectiveIncomeTaxRateReconciliationPatentBoxIncentiveBenefitPercent	0.070
CY2018	jazz	Effective Income Tax Rate Reconciliation Patent Box Incentive Benefit Percent EffectiveIncomeTaxRateReconciliationPatentBoxIncentiveBenefitPercent	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.025
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0
CY2020	jazz	Effective Income Tax Rate Reconciliation Estimated Loss Contingency Percent EffectiveIncomeTaxRateReconciliationEstimatedLossContingencyPercent	0
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	62561000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	49063000	USD
CY2019	jazz	Effective Income Tax Rate Reconciliation Estimated Loss Contingency Percent EffectiveIncomeTaxRateReconciliationEstimatedLossContingencyPercent	0
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	26090000	USD
CY2018	jazz	Effective Income Tax Rate Reconciliation Estimated Loss Contingency Percent EffectiveIncomeTaxRateReconciliationEstimatedLossContingencyPercent	0.008
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	-0.014
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.011
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.005
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.122
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.161
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.151
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	89216000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	91295000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	258296000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	225681000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	153562000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	157549000	USD
CY2020Q4	jazz	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	31787000	USD
CY2019Q4	jazz	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	33847000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	26091000	USD
CY2020Q4	jazz	Deferred Tax Assets Indirect Effects Of Unrecognized Tax Benefits DeferredTaxAssetsIndirectEffectsOfUnrecognizedTaxBenefits	48743000	USD
CY2019Q4	jazz	Deferred Tax Assets Indirect Effects Of Unrecognized Tax Benefits DeferredTaxAssetsIndirectEffectsOfUnrecognizedTaxBenefits	39432000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	82490000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	48631000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	752745000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	671589000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	77342000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	66307000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	675403000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	605282000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	448310000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	536085000	USD
CY2020Q4	jazz	Deferred Tax Liabilities Operating Lease Right Of Use Asset DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset	26316000	USD
CY2019Q4	jazz	Deferred Tax Liabilities Operating Lease Right Of Use Asset DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset	28442000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	76258000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	43447000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	550884000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	607974000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	124519000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2692000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	11000000.0	USD
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5100000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	9100000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	254916000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	221403000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	130397000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	224095000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	124519000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2692000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	77300000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	66300000	USD
CY2020Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	1900000000	USD
CY2019Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	1600000000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	124319000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	118213000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	106162000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	27908000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	27552000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	22649000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	19712000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	761000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	7584000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	213000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	91000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	25169000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	554854000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	22116000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	18182000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	146557000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	124319000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	118213000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	11300000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	7400000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	93000000.0	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	78800000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	534726000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	562436000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	600888000	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	665517000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	501548000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	530195000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	611146000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-157833000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	114801000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	148234000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	133414000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.82
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.07
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.67
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.39
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.82
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.06
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.64
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.33
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	508186000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	534133000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	537702000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	500921000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	581740000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	469825000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	495747000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	541178000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	85201000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	261898000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	102276000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	73992000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.49
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.62
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.80
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.31
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.47
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.56
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.78
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2020Q1	jazz	Upfront And Milestone Payments Expense UpfrontAndMilestonePaymentsExpense	202300000	USD
CY2020Q4	jazz	Upfront And Milestone Payments Expense UpfrontAndMilestonePaymentsExpense	36000000.0	USD
CY2019Q1	jazz	Upfront And Milestone Payments Expense UpfrontAndMilestonePaymentsExpense	56000000.0	USD
CY2019Q3	jazz	Upfront And Milestone Payments Expense UpfrontAndMilestonePaymentsExpense	48300000	USD
CY2020Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	136100000	USD
CY2019Q2	jazz	Discrete Income Tax Expense Benefit Resulting From Intra Entity Intellectual Property Asset Transfer DiscreteIncomeTaxExpenseBenefitResultingFromIntraEntityIntellectualPropertyAssetTransfer	-112300000	USD

Files In Submission

Name	View Source	Status
0001232524-21-000016-index-headers.html	Edgar Link	pending
0001232524-21-000016-index.html	Edgar Link	pending
0001232524-21-000016.txt	Edgar Link	pending
0001232524-21-000016-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_01.jpg	Edgar Link	pending
image_51.jpg	Edgar Link	pending
jazz-20201231.htm	Edgar Link	pending
jazz-20201231.xsd	Edgar Link	pending
jazz-20201231_cal.xml	Edgar Link	unprocessable
jazz-20201231_def.xml	Edgar Link	unprocessable
jazz-20201231_g1.jpg	Edgar Link	pending
jazz-20201231_htm.xml	Edgar Link	completed
jazz-20201231_lab.xml	Edgar Link	unprocessable
jazz-20201231_pre.xml	Edgar Link	unprocessable
jazzq42020ex1012.htm	Edgar Link	pending
jazzq42020ex1033c.htm	Edgar Link	pending
jazzq42020ex1033d.htm	Edgar Link	pending
jazzq42020ex108.htm	Edgar Link	pending
jazzq42020ex211.htm	Edgar Link	pending
jazzq42020ex231.htm	Edgar Link	pending
jazzq42020ex311.htm	Edgar Link	pending
jazzq42020ex312.htm	Edgar Link	pending
jazzq42020ex321.htm	Edgar Link	pending
jazzq42020ex47.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz

2020 Q4 Form 10-K Financial Statement

#000123252421000016 Filed on February 23, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JAZZ Jazz Pharmaceuticals PLC Stock $jazz

2020 Q4 Form 10-K Financial Statement

#000123252421000016 Filed on February 23, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz